Now showing items 1-1 of 1

    • Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target 

      Walker, LM; Phogat, SK; Chan-Hui, PY; Wagner, D; Phung, P; Goss, JL; Wrin, T; Simek, MD; Fling, S; Mitcham, JL; Lehrman, JK; Priddy, FH; Olsen, OA; Frey, SM; Hammond, PW; Protocol G Principal Investigators; Kaminsky, S; Zamb, T; Moyle, M; Koff, WC; Poignard, P; Burton, DR (University of NairobiSchool of medicine,University of NairobiDepartment of Immunology and Microbial Science, 2009-10)
      Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we have examined neutralization breadth in ...